The $90 central target is not a published consensus; it is an average calculated from current, attributable analyst targets. Reviewing roughly a dozen individual price targets issued in recent months — most revised after the company's most recent quarterly report — the figures cluster between $62 (Truist, Hold) and $120 (KeyBanc, Buy), with a few older Street-highs near $135. The arithmetic mean of the current set is approximately $91, rounded to a clean $90. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Views differ sharply. The cautious end includes Truist at $62, Wells Fargo at $70, and Citi at $75 (Buy). The middle is anchored by Raymond James at $80, with UBS, Jefferies, and Needham each at $85. More bullish targets include Cantor Fitzgerald and J.P. Morgan at $100, Rosenblatt at $115, Evercore ISI at $117, and KeyBanc at $120.
Post-earnings revisions were almost entirely downward. Raymond James cut its target to $80 from $125, Jefferies to $85 from $100, UBS to $85 from $105, Needham to $85 from $120, and Cantor Fitzgerald to $100 from $125. Analysts cited lower earnings expectations, margin resets, and reduced market multiples, even as most kept Buy or Overweight ratings.
At a closing price of $58.35, MCHP would need to rise roughly 54% to reach $90. That is a very large move, implying the stock must reverse a steep downturn: shares fell about 10% in a single session after the company reported quarterly results that beat expectations but issued guidance with a midpoint below estimates.
The path is tied to the semiconductor cycle. Microchip's revenue collapsed from a peak of $8.44 billion in fiscal 2023 to $4.40 billion in fiscal 2025 as customers worked through excess inventory. Fiscal 2026 revenue of $4.71 billion marked the turn, and analysts project roughly $6.4 billion in fiscal 2027. If that recovery holds and margins normalize, the current valuation could expand.
The sharp single-session decline leaves MCHP below the round-number $60 level, which may now act as a near-term psychological reference point. Because the stock fell through a broad trading range on elevated volume, any recovery toward $90 would require reclaiming that zone and sustaining momentum; no verified long-term support or resistance level should be assumed beyond these observations.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual analysts differ. Investors should watch upcoming quarterly results and guidance, analyst target revisions, inventory and booking trends across the semiconductor supply chain, margin recovery, and interest-rate and macroeconomic signals that influence cyclical chip demand.
Whether MCHP can reach $90 depends on the durability of the semiconductor recovery and on margins stabilizing faster than the market currently expects. The $90 figure — the rounded average of current analyst targets — implies roughly 54% upside, a very large move that would require the stock to reclaim ground lost in its post-earnings selloff. Supportive factors include recovering bookings, an expanding backlog, and strong projected EPS growth, while the principal obstacles are below-estimate guidance, margin pressure, supply constraints, and a wide, visibly cautious analyst range. With targets spanning $62 to $120, there is no consensus on timing; investors should monitor quarterly guidance and demand signals before drawing conclusions.
In my own research workflow, I turn to Tickeron’s AI Daily Buy/Sell Signals to track shifts in momentum and generate data-driven signals across volatile names like this one. The platform continuously scans thousands of stocks and ETFs, helping me spot changing trends more efficiently alongside traditional analysis. It serves as a practical complement when evaluating recovery candidates in the semiconductor space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +8.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCHP advanced for three days, in 194 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
MCHP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCHP as a result. In 83 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for MCHP turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 33 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
MCHP moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MCHP crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCHP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. MCHP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.912) is normal, around the industry mean (5.443). P/E Ratio (85.809) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.233) is also within normal values, averaging (3.803). Dividend Yield (0.031) settles around the average of (0.014) among similar stocks. P/S Ratio (7.446) is also within normal values, averaging (46.468).
The Tickeron SMR rating for this company is 82 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCHP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of microcontrollers for high volume embedded control applications
Industry Semiconductors